Neuromodulation Devices Report 2016-2026 : Revenue Forecasts for Deep Brain Stimulation, Spinal Cord, Vagus Nerve, Sacral Nerve and Gastric Electrical Applications

神経調節装置の世界市場:脳深部刺激、脊髄、仙椎神経、胃部用途

◆タイトル:Neuromodulation Devices Report 2016-2026 : Revenue Forecasts for Deep Brain Stimulation, Spinal Cord, Vagus Nerve, Sacral Nerve and Gastric Electrical Applications
◆商品コード:VGAIN6041533
◆調査・発行会社:visiongain
◆発行日:2016年3月
◆ページ数:200
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名利用)GBP1,999 ⇒換算¥309,845見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥464,845見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥774,845見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"神経調節装置の世界市場:脳深部刺激、脊髄、仙椎神経、胃部用途"について調査・分析し、レポートサマリー、市場動向、世界市場規模・市場予測、地域別市場分析、主要国別市場分析、市場環境分析、専門家の見解、結論などの情報をお届けいたします。

Neuromodulation devices – your 2016 guide to trends, opportunities and future revenuesDiscover the future of medical devices to stimulate and treat the central nervous system. Neuromodulation devices hold high, rising sales potential. Now you can explore forecasts and see predicted revenues. Assess the expected gains.

Visiongain’s updated report predicts those revenues to 2026 at overall world market, submarket and national level. With our new survey you stay ahead in that CNS data and analysis, discovering medical, technological and commercial opportunities and prospects.

With that study you explore what the future holds for those companies. Read on now to investigate neuronal devices, also seeing a revenue prediction below.

Forecasts and other analyses to help your research, knowledge and influence
Do you struggle to find business data on neuromodulation and neurostimulation therapies? Instead today discover potentials of those treatments for brain and other nervous system disorders. Our report analyses the future of that healthcare industry, showing potential gains.

With that updated study make your research, analyses and plans easier and quicker. That way you can also benefit your reputation for commercial insight. See what is possible.

In addition to multilevel forecasting to 2026, our new study shows you results, growth rates, market shares, opinions and discussions. In that report you gain 65 charts, 30 tables and interviews with two organisations. Our work’s purpose is to help you stay ahead.

There discover how competition and technological advances shape that industry. Also benefit your knowledge and authority. See what sales are possible from 2016 in the neuromodulators industry and investigate how you can gain. Sections below explain.

Forecasting of that world market and its segments – what is possible?
Our study predicts overall world revenue to 2026 for neuromodulating and neurostimulating technologies.

There, in our work, you also find individual revenue predictions to 2026 for six submarkets at world level:
• Spinal cord stimulation (SCS)
• Deep brain stimulation (DBS)
• Vagus/vagal nerve stimulation (VNS)
• Sacral nerve stimulation (SNS)
• Gastric electrical stimulation (GES)
• Other techniques (grouped forecast), including trigeminal nerve stimulation, cochlear implants, transcranial magnetic stimulation, transcranial direct current stimulation and ultrasonic neuromodulation.

With that analysis you investigate the most promising and lucrative parts of the neuromodulators industry. See how it can progress. Our study predicts high, rising sales. You explore where, when, how and why market expansion can occur.

Our investigation also splits its overall world market into geographical revenue predictions.

National markets – what outlooks for neuromodulators’ sales?
Our analyses also show you individual revenue forecasts to 2026 for 11 countries:
• United States
• Japan
• Germany, France, United Kingdom, Italy and Spain (EU5 group)
• Brazil, Russia, India and China (BRIC countries).

Healthcare developments worldwide stimulate that industry’s revenues. With our data you find countries with highest revenues, demand and potential sales. See needs and opportunities. And explore the expected trends, progress and gains.

So how do changes, challenges and technological advances affect that industry and market?

Forces, events and issues influencing that medical devices field
Our updated report explains policies, trends and R&D shaping that industry and market, including these developments:
• Widening applications in treating pain, depression, epilepsy, incontinence, hearing disorders, heart conditions and neurodegenerative diseases, inc. Parkinson’s
• Market trends – ageing populations raising demand, personalised healthcare, regulations and changes in that medical devices segment
• Emerging technology – cochlear implants, transmagnetic stimulation (TMS), transcranial direct current stimulation (tDCS) and ultrasonic applications.

With that work you assess the industry’s strengths, weaknesses, opportunities and threats, also exploring social, technological, economic and political questions. Those analyses help you assess what stimulates and restrains companies. Explore what the future holds.

Neuromodulation technology – leading companies and 2020 market value
What happens next? From 2016 neuromedical devices hold great potential for investments, medical advances and sales. Our report predicts the world market for those products will reach $9.3bn in 2020, with fast 2016-2026 sales growth. High potentials exist for companies.

In particular our study discusses performances, activities and potentials of four leading organisations:
• Medtronic
• Boston Scientific
• St. Jude Medical
• Cyberonics.

Discussions of rising companies appear too. The survey also shows visiongain’s interviews with the International Neuromodulation Society and NeuroSigma.

【レポートの目次】

1. Report Overview
1.1 Overview of the World Market for Neuromodulation Devices
1.2 Why You Should Read This Report
1.3 How this Report Delivers
1.4 Main Questions Answered by this Analysis
1.5 Who is this Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain

2. Introduction to Neuromodulation
2.1 Neuromodulation
2.2 Techniques Used in Neuromodulation
2.2.1 Electrical Stimulation Techniques
2.2.1.1 Brain and Spinal Cord Therapies
2.2.1.2 Cranial Nerve Stimulation
2.2.1.3 Functional Electrical Stimulation
2.2.2 Pharmacological Therapy
2.3 Application of Neuromodulation
2.3.1 Pain
2.3.2 Depression
2.3.3 Epilepsy
2.3.4 Faecal and Urinary Incontinence
2.3.5 Hearing Disorders – Profound Deafness
2.3.6 Cardiovascular Diseases – Arrhythmia and Angina
2.3.7 Neurodegenerative Diseases – Parkinson’s Disease

3. The Global Neuromodulation Devices Market, 2016-2026
3.1 Global Neuromodulation Devices Market: 2015
3.2 Global Neuromodulation Devices Forecast: 2015-2026
3.3 Neuromodulation Devices: Industry Trends, 2016-2026
3.3.1 Industry Trends – Ageing Population
3.3.2 Rising Prevalence of Chronic Diseases
3.3.3 Industry Trends – Personalised Healthcare
3.3.4 Industry Trends – National Regulations
3.3.5 Political Uncertainty and Security Risk across the World
3.3.6 Industry Trends – Economic Challenges
3.3.7 Industry Trends – Mergers and Acquisitions

4. Spinal Cord Stimulation Submarket, 2016-2026
4.1 Spinal Cord Stimulation (SCS) Market Overview, 2015
4.2 SCS Market Forecast: 2015-2026
4.3 Top Selling SCS Devices, 2016
4.4 Applications of Spinal Cord Stimulation
4.5 SCS Market Trends: 2016-2026

5. Deep Brain Stimulation Submarket, 2016-2026
5.1 Deep Brain Stimulation (DBS) Market Overview, 2015
5.2 DBS Market Forecast: 2015-2026
5.3 Top Selling DBS Devices, 2016
5.4 Applications of Deep Brain Stimulation
5.5 DBS Market Trends: 2016-2026

6. Gastric Electrical Stimulation Submarket, 2016-2026
6.1 Gastric Electrical Stimulation (GES) Market Overview, 2015
6.2 GES Market Forecast: 2015-2026
6.3 Top Selling GES Devices, 2016
6.4 Applications of Gastric Electrical Stimulation
6.5 GES Market Trends: 2016-2026

7. Vagus Nerve Stimulation Submarket, 2016-2026
7.1 Vagus Nerve Stimulation (VNS) Market Overview, 2015
7.2 VNS Market Forecast: 2015-2026
7.3 Top Selling VNS Devices, 2016
7.4 Applications of Vagus Nerve Stimulation
7.5 VNS Market Trends: 2016-2026

8. Sacral Nerve Stimulation Submarket, 2016-2026
8.1 Sacral Nerve Stimulation (SNS) Market Overview, 2015
8.2 SNS Market Forecast: 2016-2026
8.3 Top Selling SNS Devices; 2016
8.4 Applications of Sacral Nerve Stimulation
8.5 SNS Market Trends: 2016-2026

9. Other Neuromodulation Technologies Submarket, 2016-2026
9.1 Other Neuromodulation Technologies Overview, 2015
9.1.1 Trigeminal Nerve Stimulation
9.1.2 Cochlear Implants
9.1.3 Transcranial Magnetic Stimulation (TMS)
9.1.4 Transcranial Direct Current Stimulation (tDCS)
9.1.5 Ultrasonic Neuromodulation
9.2 Other Neuromodulation Techniques Forecast: 2015-2026

10. Neuromodulation Devices in Leading National Developed Markets, 2016-2026
10.1 Neuromodulation Devices: Leading Developed Markets, 2015
10.2 The US Neuromodulation Devices Market: 2016-2026
10.2.1 The US Neuromodulation Devices Market: 2015
10.2.2 The US Neuromodulation Devices Market Forecast: 2015-2026
10.3 The Japanese Neuromodulation Devices Market: 2016-2026
10.3.1 The Japanese Neuromodulation Devices Market: 2015
10.3.2 The Japanese Neuromodulation Devices Market Forecast: 2015-2026
10.3.3 The Effects of Regulations on the Japanese Market
10.4 The German Neuromodulation Devices Market: 2016-2026
10.4.1 The German Neuromodulation Devices Market: 2015
10.4.2 The German Neuromodulation Devices Market Forecast: 2015-2026
10.5 The French Neuromodulation Devices Market: 2016-2026
10.5.1 The French Neuromodulation Devices Market: 2015
10.5.2 The French Neuromodulation Devices Market Forecast: 2015-2026
10.5.3 The French Neuromodulation Devices Market – the Economy and its Implications
10.6 The Italian Neuromodulation Devices Market: 2016-2026
10.6.1 The Italian Neuromodulation Devices Market: 2015
10.6.2 The Italian Neuromodulation Devices Market Forecast: 2015-2026
10.6.3 The Italian Neuromodulation Devices Market Outlook
10.7 The UK Neuromodulation Devices Market: 2016-2026
10.7.1 The UK Neuromodulation Devices Market: 2015
10.7.2 The UK Neuromodulation Devices Market Forecast: 2015-2026
10.7.3 The UK Neuromodulation Devices Market Forecast – Political Challenges
10.8 The Spanish Neuromodulation Devices Market: 2016-2026
10.8.1 The Spanish Neuromodulation Devices Market: 2015
10.8.2 The Spanish Neuromodulation Devices Market Forecast: 2015-2026
10.8.3 The Spanish Neuromodulation Devices Outlook

11. Neuromodulation Devices in Leading Emerging Markets, 2016-2026
11.1 Neuromodulation Devices: Leading Emerging Markets, 2015
11.2 The Brazilian Neuromodulation Devices Market: 2016-2026
11.2.1 The Brazilian Neuromodulation Devices Market: 2015
11.2.2 The Brazilian Neuromodulation Device Market Forecast: 2015-2026
11.2.3 The Brazilian Neuromodulation Devices Market: Economic and Political Challenges Affecting Prospects
11.3 The Chinese Neuromodulation Devices Market: 2016-2026
11.3.1 The Chinese Neuromodulation Devices Market: 2015
11.3.2 The Chinese Neuromodulation Devices Market Forecast: 2015-2026
11.3.3 The Chinese Neuromodulation Devices Market: Amendments to Regulations.
11.4 The Indian Neuromodulation Devices Market: 2016-2026
11.4.1 The Indian Neuromodulation Devices Market: 2015
11.4.2 The Indian Neuromodulation Devices Market Forecast: 2015-2026
11.4.3 The Indian Neuromodulation Devices Market: What’s Possible in that Rising Industrial Power?
11.5 The Russian Neuromodulation Devices Market: 2016-2026
11.5.1 The Russian Neuromodulation Devices Market: 2015
11.5.2 The Russian Neuromodulation Devices Market Forecast: 2015-2026

12. Neuromodulation Devices Market: Manufacturers
12.1 Medtronic
12.1.1 Sales and Recent Performance Analysis: 2015
12.1.2 Medtronic International Operations
12.1.3 Medtronic-Neuromodulation Performance
12.1.4 Medtronic News
12.1.4.1 Medtronic Mergers
12.1.4.2 Expansion into DBS Market
12.1.4.3 Medtronic Products
12.1.5 Medtronic-Market Outlook
12.2 Boston Scientific
12.2.1 Sales and Recent Performance Analysis: 2015
12.2.2 Boston Scientific International Operations
12.2.3 Boston Scientific-Neuromodulation Performance
12.2.4 Boston Scientific News
12.2.4.1 Boston Scientific Acquisitions
12.2.4.2 Expansion into DBS Market
12.2.4.3 Boston Scientific Products
12.2.5 Boston Scientific-Market Outlook
12.3 St. Jude Medical (SJM)
12.3.1 Sales and Recent Performance Analysis: 2015
12.3.2 SJM International Operations
12.3.3 SJM-Neuromodulation Performance
12.3.4 SJM News
12.3.4.1 SJM Acquisitions
12.3.4.2 SJM Products
12.3.5 SJM – Market Outlook
12.4 Cyberonics
12.4.1 Sales and Recent Performance Analysis: 2015
12.4.2 Cyberonics International Operations
12.4.3 Cyberonics – Neuromodulation Performance
12.4.4 Cyberonics News
12.4.4.1 Cyberonics Investments
12.4.4.2 Cyberonics Products
12.4.5 Cyberonics-Market Outlook
12.5 Other Companies
12.5.1 Stryker Corporation
12.5.2 Nevro Corp.
12.5.3 SetPoint Medical
12.5.4 Functional Neuromodulation
12.5.5 Neurotherapies Reset
12.5.6 Wiringless Implantable Stretchable Electronics (WISE)
12.5.7 SceneRay
12.5.8 Mindray

13. Qualitative Analysis of the Neuromodulation Devices Market, 2016
13.1 SWOT Analysis of the Neuromodulation Devices Market
13.1.1 Strengths of the Market
13.1.1.1 An Ageing Population
13.1.1.2 Alternative Form of Treatment
13.1.1.3 Convenience
13.1.1.4 Long-term Effectiveness
13.1.2 Weaknesses
13.1.2.1 Research and Development (R&D)
13.1.2.2 Oligarchic Market
13.1.2.3 Adverse Side-Effects of Implantation
13.1.2.4 Shortage of Trained Professionals
13.1.3 Opportunities in the Neuromodulation Devices Market
13.1.3.1 The Advancement of Research
13.1.3.2 A Shift Towards Personalisation
13.1.3.3 Expanding the Target Applications of the Devices
13.1.3.4 Outsource Manufacturing of Devices
13.1.4 Threats Facing the Neuromodulation Devices Market
13.1.4.1 The Challenge of Regulation
13.2 STEP Analysis of the Neuromodulation Devices Market
13.2.1 Social Factors: The Role of Neuroethics
13.2.2 Technological Developments: Drive towards Non-Invasive Methods
13.2.3 Economic Restraints: High Production Costs
13.2.4 Economic Potential: Emerging Markets Create Demand
13.2.5 Political Issues: Strong Government Influence

14. Research Interviews
14.1 Dr Timothy Deer, President, International Neuromodulation Society
14.1.1 International Neuromodulation Society
14.1.2 Landscape of the Current Neuromodulation Market
14.1.3 Future Directions of the Neuromodulation Industry
14.2 Dr Leon Ekchian, CEO, NeuroSigma, US
14.2.1 NeuroSigma
14.2.2 Understanding the Trigeminal Nerve Stimulation Therapy
14.2.3 Challenges as a Neuromodulation Device Manufacturer
14.2.4 Future Directions of the Neuromodulation Industry

15. Conclusions
15.1 The United States Retains its Position as Market Leader
15.2 Growing Incidences of Neurological Diseases
15.3 Ageing Population Drives Growth
15.4 China and India will Lead the Emerging Markets
15.5 The Future of the Market – Deep Brain Stimulation and Vagus Nerve Stimulation
15.6 Concluding Remarks

List of Tables
Table 1.1 Selected National Neuromodulation Devices Markets: Revenues ($m) and Market Shares (%) by Leading Country, 2014, 2020 and 2026
Table 3.1 Neuromodulation Devices Submarkets: Revenue ($bn), Annual Growth (%), CAGR (%), Market Share (%), 2014-2026
Table 3.2 Global Neuromodulation Devices Market: Revenue ($bn), Annual Growth (%), CAGRs (%), 2014-2026
Table 4.1 SCS Devices Forecast ($bn), Annual Growth (%), Market Share and CAGR (%), 2015-2026
Table 4.2 Leading SCS Devices, 2016
Table 5.1 The DBS Devices Forecast ($bn), Annual Growth (%), Market Share and CAGR (%), 2015-2026
Table 5.2 Leading DBS Devices, 2016
Table 6.1 The GES Devices Forecast ($bn), Annual Growth (%), Market Share and CAGR (%), 2015-2026
Table 6.2 Leading GES Devices, 2016
Table 7.1 The VNS Devices Forecast ($bn), Annual Growth, (%), Market Share and CAGR (%), 2015-2026
Table 7.2 Leading VNS Devices, 2016
Table 8.1 The SNS Devices Forecast ($bn), Annual Growth (%), Market Share and CAGR (%), 2015-2026
Table 8.2 Leading SNS Devices, 2016
Table 9.1 Other Neuromodulation Devices Market: Revenue Forecast ($bn), Annual Growth (%), Market Share and CAGR (%), 2015-2026
Table 10.1 Regional Neuromodulation Device Markets: Revenue ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2014-2026
Table 10.2 US Neuromodulation Devices: Revenue Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
Table 10.3 Japanese Neuromodulation Devices Revenue Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
Table 10.4 German Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
Table 10.5 French Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
Table 10.6 Italian Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
Table 10.7 UK Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
Table 10.8 Spanish Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
Table 11.1 Neuromodulation Devices Emerging Markets: Revenue ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2014-2026
Table 11.2 Brazilian Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
Table 11.3 Chinese Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
Table 11.4 Indian Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
Table 11.5 Russian Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
Table 12.1 Medtronic Neuromodulation Revenue ($bn), 2012-2014
Table 12.2 Boston Scientific Neuromodulation Revenue ($bn), 2012-2014
Table 12.3 SJM Neuromodulation Revenue ($bn), 2012-2014
Table 12.4 Cyberonics Neuromodulation Revenue ($bn), 2011-2015

List of Figures
Figure 1.1 Neuromodulation Devices Market Segmentation, 2016
Figure 3.1 Global Neuromodulation Devices Market Share (%) Segmentation, 2015
Figure 3.2 Global Neuromodulation Devices Market: Revenue ($bn), AGR (%), 2014-2026
Figure 3.3 Global Neuromodulation Devices Market Share (%) Segmentation, 2026
Figure 3.4 Global Neuromodulation Devices Market: Drivers and Restraints, 2016-2026
Figure 4.1 SCS Devices Market Share (%) Segmentation, 2015
Figure 4.2 SCS Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 5.1 DBS Devices Market Share (%) Segmentation, 2015
Figure 5.2 DBS Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 6.1 GES Devices Market Share (%) Segmentation, 2015
Figure 6.2 GES Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 7.1 VNS Devices Market Share (%) Segmentation, 2015
Figure 7.2 VNS Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 8.1 SNS Devices Market Share (%) Segmentation, 2015
Figure 8.2 SNS Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 9.1 Other Neuromodulation Devices Market Share (%) Segmentation, 2015
Figure 9.2 Other Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 10.1 Regional Neuromodulation Devices Market Shares (%), 2015
Figure 10.2 Regional Neuromodulation Devices Market Shares (%), 2026
Figure 10.3 Developed National Markets: Drivers and Restraints, 2016-2026
Figure 10.4 The US Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 10.5 The Japanese Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 10.6 German Neuromodulation Devices Market Share (%) within the EU, 2015
Figure 10.7 The German Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 10.8 French Neuromodulation Devices Market Share (%) within the EU, 2015
Figure 10.9 The French Neuromodulation Device Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 10.10 Italian Neuromodulation Devices Market Share (%) within the EU, 2015
Figure 10.11 The Italian Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 10.12 UK Neuromodulation Devices Market Share (%) within the EU, 2015
Figure 10.13 The UK Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 10.14 Spanish Neuromodulation Devices Market Share (%) within the EU, 2015
Figure 10.15 Spanish Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 11.1 BRIC Neuromodulation Devices Market Shares (%), 2015
Figure 11.2 BRIC Neuromodulation Devices Market Shares (%), 2026
Figure 11.3 Emerging National Markets: Drivers and Restraints, 2016-2026
Figure 11.4 Brazilian Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 11.5 Chinese Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 11.6 Indian Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 11.7 Russian Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
Figure 12.1 Medtronic Revenue ($bn), 2010-2015
Figure 12.2 Medtronic Operating Sectors (%), 2015
Figure 12.3 Medtronic Sales Shares (%), 2015
Figure 12.4 Medtronic Geographical Sales Shares (%), 2015
Figure 12.5 Medtronic Neuromodulation Revenue Shares (%) within Restorative Therapies, 2015
Figure 12.6 Medtronic Neuromodulation Revenue ($bn), 2012-2014
Figure 12.7 Boston Scientific Revenue ($bn), 2010-2014
Figure 12.8 Boston Scientific Operating Sectors (%), 2015
Figure 12.9 Boston Scientific Sector Shares (%), 2015
Figure 12.10 Boston Scientific World Sales Shares (%), 2015
Figure 12.11 Boston Scientific Geographical Sales Shares (%), 2015
Figure 12.12 Boston Scientific Neuromodulation Revenue ($bn), 2012-2014
Figure 12.13 Boston Scientific Neuromodulation Revenue Shares (%) within Med-Surgical Sector, 2015
Figure 12.14 St. Jude Medical Revenue ($bn), 2010-2014
Figure 12.15 St. Jude Medical Operating Sectors (%), 2015
Figure 12.16 St. Jude Medical World Sales Shares (%), 2014
Figure 12.17 St. Jude Medical Geographical Sales Shares (%), 2014
Figure 12.18 St. Jude Medical Revenue Distribution ($bn), 2013-2014
Figure 12.19 St. Jude Medical Sales Distribution ($bn), Q1 2014 to Q3 2014
Figure 12.20 St. Jude Medical Neuromodulation Revenue ($bn), 2012-2014
Figure 12.21 St. Jude Medical Neuromodulation Devices Quarterly Analysis ($bn), 2013-2014
Figure 12.22 Cyberonics Revenue ($bn), 2010-2015
Figure 12.23 Cyberonics World Sales Shares (%), 2015
Figure 12.24 Cyberonics Sales Distribution ($bn), 2013-2015
Figure 13.1 SWOT Analysis of the Neuromodulation Devices Market, 2016
Figure 13.2 STEP Analysis of the Neuromodulation Devices Market, 2016

【レポートのキーワード】

神経調節装置、脳深部刺激、脊髄、仙椎神経、胃部用途

★調査レポート[神経調節装置の世界市場:脳深部刺激、脊髄、仙椎神経、胃部用途] ( Neuromodulation Devices Report 2016-2026 : Revenue Forecasts for Deep Brain Stimulation, Spinal Cord, Vagus Nerve, Sacral Nerve and Gastric Electrical Applications / VGAIN6041533) 販売に関する免責事項
[神経調節装置の世界市場:脳深部刺激、脊髄、仙椎神経、胃部用途] ( Neuromodulation Devices Report 2016-2026 : Revenue Forecasts for Deep Brain Stimulation, Spinal Cord, Vagus Nerve, Sacral Nerve and Gastric Electrical Applications / VGAIN6041533) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆